NSE · LINCOLN
Lincoln Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,465
of 5,096 stocks
▼ 81W
Peak #1,457 · 21 Sep 2026
Operating in Healthcare, Lincoln Pharmaceuticals Limited is growing revenue modestly, trades at a moderate earnings multiple, and posts a modest return on equity.
Market Cap
1,165.43 Cr
P/E Ratio
13.26
P/B Ratio
1.54
ROE
11.60%
ROCE
14.97%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 177.28 Cr | 187.28 Cr | 166.32 Cr | 163.36 Cr |
| Net Profit | 36.23 Cr | 11.63 Cr | 28.60 Cr | 19.98 Cr |
| EPS | 18.09 | 5.81 | 14.28 | 9.98 |
| Operating Profit | 47.81 Cr | 16.98 Cr | 35.02 Cr | 29.04 Cr |
Shareholding pattern
Promoter
49.78%
Public
50.22%
Mutual fund holdings
₹0.02
Cr total
2
Schemes
2
Fund Houses
₹0.02 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.02 Cr (65.0%)
Bandhan Mutual Fund₹0.01 Cr (35.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Sep 2025 | Dividend | Dividend - Rs 1.80 Per Share |
| 13 Sep 2024 | Dividend | Dividend - Rs 1.80 Per Share |
| 15 Sep 2023 | Dividend | Annual General Meeting/Dividend - Rs 1.50 Per Share |
| 15 Sep 2022 | Dividend | Annual General Meeting/Dividend - Rs 1.50 Per Share |
| 16 Sep 2021 | Dividend | Dividend - Rs 1.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.